During this segment, Bruce Feinberg; DO; Scott Gottlieb, MD; Brian Kiss, MD; and Michael Kolodziej, MD, highlight the issues that payers are encountering with the increased utilization of oral oncolytics and discuss how these issues are being addressed.
Dr Feinberg remarks that oral oncolytics are associated with high costs, which affects adherence, medication therapy management, and overall cost.
Payers are trying to manage these issues by splitting out “specialty pharmacy” medications and working with vendors to negotiate better prices, comments Dr Kiss. However, payment systems are becoming more complex and it is challenging to ensure that oncologists know to which types of pharmacies they should refer their patients for savings.
Professionals are recognizing an increased amount of drug wastage in the handling of these therapies, adds Dr Kiss. For example, many oral oncolytic prescriptions can be ordered via mail. Patients receive a large supply of their oral oncolytic; however, they may need to stop taking the medication due to tolerance issues.
Dr Kolodziej and Dr Gottlieb discuss the systems that pharmacy benefit managers have established in an attempt to resolve these issues.
Can Medicare Sustain Widespread Access to GLP-1 Therapies?
April 25th 2025Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Science at AACR Aims to Overcome Cancer Care Barriers
April 24th 2025A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.
Read More
Top Pharmacy Leaders to Convene at Asembia’s AXS25 Summit in Las Vegas
April 24th 2025Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las Vegas, Nevada.
Read More